Table 1. Patient Characteristics.
| Patient Characteristics | |
|---|---|
| Age (years) | |
| Median [Range] | 40 [2-68] |
| <18 | 69 |
| <18-30 | 64 |
| 30-49 | 150 |
| >50 | 92 |
| Disease | |
| AML | 150 |
| ALL | 85 |
| CML | 55 |
| NHL | 49 |
| MDS | 36 |
| Donor | |
| Matched Related | 202 |
| Mismatched Related | 36 |
| Matched Unrelated | 77 |
| Mismatched unrelated | 60 |
| Status at HSCT | |
| 1st complete remission, 1st chronic phase, untreated MDS without increased blasts | 178 |
| active relapse, refractory disease, progressive disease | 22 |
| Other | 175 |
| Conditioning Regimen | |
| TBI/Thiotepa/Cyclophosphamide | 218 |
| TBI/Thiotepa/Fludarabine | 109 |
| Busulfan/Melphalan/Fludarabine | 48 |
| Stem Cell Source | |
| Bone Marrow | 190 |
| Peripheral Blood Stem Cells | 153 |
| Bone Marrow & Peripheral Blood Stem Cells | 32 |
AML: acute myelogenous leukemia; ALL: acute lymphoblastic leukemia; CML: chronic myelegenous leukemia; NHL: non-Hodgkin lymphoma; MDS: Myelodysplastic syndrome; HSCT: hematopoietic stem cell transplantation; TBI: total body irradiation.